AIC
AMPH icon

Aurora Investment Counsel’s Amphastar Pharmaceuticals AMPH Stock Holding History

Aurora Investment Counsel’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,253
Closed -$1.22M – 108
2025
Q2 		$1.22M Sell
53,253
-828
-2% -$20.5K 0.64% 84
2025
Q1 		$1.57M Sell
54,081
-624
-1% -$19.9K 0.87% 59
2024
Q4 		$2.03M Buy
54,705
+7
+0% +$320 1.11% 36
2024
Q3 		$2.65M Buy
54,698
+232
+0.4% +$10.2K 1.44% 10
2024
Q2 		$2.18M Buy
+54,466
New +$2.26M 1.28% 20

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aurora Investment Counsel's AMPH Position: Q3 2025 in Review

Aurora Investment Counsel sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 53,253 shares — an estimated $1.22M sold.

Aurora Investment Counsel first reported a position in AMPH in Q2 2024 and held it in 5 quarters. The position peaked at $2.65M in Q3 2024. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

  • Aurora Investment Counsel reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Aurora Investment Counsel sold 53,253 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $1.22M.
  • Aurora Investment Counsel first reported a position in Amphastar Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Aurora Investment Counsel's Amphastar Pharmaceuticals position peaked at $2.65M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Aurora Investment Counsel's 13F filing for Q3 2025, filed 10 Nov 2025.